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COINCIDENT pregnancy and carcinoma of the breast is relatively rare. The
inicidence reported in the literature ranges from 0 43 per cent (Devitt et al., 1964)
to 4 per cent (Helman and Bennett, 1963). Most of the materials presented in
the literature comprise a couple of cases (e.g. Robinson, 1965; Donegan, 1967).
Somewhat larger materials and reviews of the literature have been published, as
for example by Westberg (1946), Adair (1953), White (1954, 1955), Holleb and
Farrow (1962), Miller (1962), Rosemond (1964) and Peters and Meakin (1965).
It was generally held earlier that the cases in which carcinoma of the breast is
comnplicated by pregnancy are rather hopeless (e.g. Bromeis, 1939; Kettunen,
1946). More recently however, a more optimistic view has been expressed in the
literature (e.g. Westberg, 1946; Brooks and Proffitt, 1949; Devitt et al., 1964;
Schumacher, 1964; Peters and Meakin, 1965). The combination of mammary
carcinoma and pregnancy is nevertheless unusual enough to warrant the publica-
tion of further experience.
MATERIAL AND METHODS
The material consisted of 33 patients in whom histologically verified carcinoma
of the breast was diagnosed during pregnancy or lactation and who were treated
in 1940-61 at the Radiotherapy Clinic, University Central Hospital, Helsinki.
This total was about 0 9 per cent of all mammary carcinomas treated at the clinic
during the same period. Thirty-one of the patients in the series developed
breast cancer during pregnancy and 2 during lactation, both the latter within
3 months of parturition. Three of the patients had another child and one had 2
deliveries later, 1-10 years after treatment for carcinoma of the breast.
The youngest patient was 25 on admission and the oldest 42; the mean age of
the series was 34 6 years. The first symptom was invariably a mass in the
mammary gland. The duration of symptoms before admission varied from 2
weeks to 2 years, mean 8 months. Some patients had thus felt a mass in the
breast before the beginning of pregnancy without reacting to it in that phase.
Nineteen of the tumours were in the right and 13 in the left breast. The
condition was bilateral in 1 case. The tumour was localised in the lateral half
of the breast in 20 cases, in the medial part in 10 cases and centrally in 3. The
tumour size varied from 3 cm. to a massive tumour about 15 cm. in diameter.
Metastatic lymph nodes in the axilla were established on admission in 25 cases,
i.e. 75 per cent.
The tumours were distributed into different groups according to the TNM
system (U.I.C.C. Publication, 1960) which is in general use today for classification
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distant metastases). There were no cases ofT1, 17 ofT2, 15 ofT3 and 1 case ofT4.
The material was distributed as follows on the basis of clinical classification:
Stage I . 5 cases
Stage II 10
Stage III . 13
Stage IV . 5
Total . 33 cases
Sixteen of the patients in whom mammary carcinoma was established during
pregnancy were in the first trimester, 3 in the second and 12 in the third trimester.
The cases of different stages were accordingly distributed as shown in Table I.
TABLE I.--Mammary Carcinomas Established in Different Stages ofPregnancy
Stage I II III IV Total
First trimester . . 3 . 7 . 5 . 1 . 16
Second trimester . . - . 1 . 2 . . 3
Third trimester . 2 1 . 6 . 3 . 12
Total . 5 . 9 . 13 . 4 . 31
The distribution according to the histological picture was:
Adenomatous carcinoma . . . 11
" Solid" carcinoma . . . . 9
Scirrhous carcinoma. . . . 3
Colloid carcinoma . . . . 1
Anaplastic carcinoma . . . 2
Carcinoma (not otherwise specified) . 7
Total . . . . . . 33
No classification into different degrees of malignancy on the basis of the
histological picture was performed.
The pregnancy was interrupted in 8 cases; 1 ofthese wasinthesecondtrimester,
all the other patients were in the first trimester. Pregnancy was interrupted
before the institution of therapy or in course of it in 2 cases and after therapy in
6 cases. Distribution of the abortions by the clinical stage of the tumour was as
follows: Stage I: 1 case, Stage II: 3 cases, Stage III: 3 cases and Stage IV: 1 case.
The various therapeutic methods employed are shown in Table II. Six patients
underwent in addition either surgical or roentgen castration primarily; 2 of them
were of Stage I, 1 of Stage II, 2 of Stage III and 1 of Stage IV.
TABLE II.-The Therapeutic Measures Employed
Stage I Stage II Stage III Stage IV
Simple mastectomy + radiotherapy postop.... 2 2 -
Radical mastectomy + radiotherapy postop. . 2 . 7 . 7 . 2
Radical mastectomy + radiotherapy preop. and. 1 . 3 . 5
postop.
Radical mastectomy + radiotherapy preop . . . 1 --
Radiotherapy alone . . . . . . . .
No specific treatment . . . . . I . -
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Preoperative roentgen therapy consisted of c. 1400 R for 3-4 weeks from two
fields to the breast and from two fields to the corresponding axilla. The treat-
ment values were generally 180-250 kv, 10-15 mA, 0 5 Cu, FSH 50 cm. The
supraclavicular fossa, the corresponding axilla and the operative area of the
breast were treated postoperatively for 4-5 weeks with a dosage of 1400-2800 R.
The 2 patients who were given radiotherapy alone received only a small palliative
dose, whereupon treatment had to be discontinued on account of the patients'
poor general condition. In one Stage IV case no specific treatment was possible
because of the patient's extremely poor general condition.
RESULTS
The follow-up period was 6-28 years from the start of therapy. Twenty-one
patients died during the follow-up period, all of them of mammary carcinoma or
its metastases; 12 patients are still alive. Thirty-three cases were followed up
for over 5 years, 28 for over 10 years, 20 for over 15 years and 12 for over 20 years.
Table III shows the survival rate for the total material. The survival rate
according to the various stages is given in Table IV.
TABLE III. Survival Rate of the Total Series
5 years 10 years 15 years 20 years
14/33 13/28 10/20 5/12
TABLE IV. Survival Rates for the Different Clinical Stages
1 year 3 years 5 years 10 years 20 years
Stage I 4/5 . 4/5 4/5 4/5 1/1
Stage II 10/10 8/10 8/10 7/9 3/4
Stage III 10/13 3/13 2/13 . 2/9 . 1/3
Stage IV 1/5 . 0/5 0/5 . 0/5 . 0/4
The 5-year survival rate for the total series was 43 per cent. But analysed
according to the different clinical stages, the 5-year rate was 80 per cent for the
Stage I cases, 80 per cent for Stage II, 15 per cent for Stage III and 0 per cent for
the patients in Stage IV of the disease. One of the patients in Stage IV lived for
1 year 3 months; the rest died within 3 months of admission.
Abortions were performed on 8 patients. Two ofthem were alive 10-15 years
after carcinoma therapy; one had carcinoma of Stage I andthe other of Stage II.
The pregnancy was interrupted in the first trimester in both these cases. All the
other patients died 3 months-6 years after treatment. One of them was of Stage
II, 4 of Stage III and one of Stage IV.
Four of the patients had further pregnancies 1-10 years after treatment for
carcinoma ofthe breast. One ofthese cases involved a primary tumour ofStage I,
1 of Stage II and 2 of Stage III. One patient in Stage III of the disease who was
delivered a year after primary therapy died from metastases 3 years after primary
therapy for carcinoma; all the other 3 patients are alive and free of symptoms
20-24 years after primary therapy.
Ofthe patients who underwent either surgical or roentgen castration primarily,
those of Stage I (2) are alive, while the patients with Stage II-IV of the disease all
died 3 months-1 year 3 months after therapy.
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DISCUSSION
Pregnancy as a complication of carcinoma of the breast is fairly rare. The
present series represented 0-9 per cent of all mammary carcinomas diagnosed
during the same period, an incidence which corresponds with most recent reports.
In contrast to the great pessimism voiced in earlierstudies (e.g. Bromeis, 1939;
Kettunen, 1946) more recent reports suggest that the prognosis of pregnant women
with carcinoma of the breast is not essentially different from the general prognosis
for young women with mammary carcinoma (e.g. Westberg, 1946; Devitt et al.,
1964; Rosemond, 1964; Schumacher, 1964; Peters and Meakin, 1965; Robinson,
1965). On the other hand, mammary carcinoma may grow unusually rapidly
during pregnancy, as has been suggested in some experimental (Bromeis, 1939;
McCormick and Moon, 1965) and clinical observations. Metastasis to the regional
lymph nodes is probably also abnormally rapid in this phase. For instance,
Harrington (1937) established metastases in the axillary lymph nodes in 84-7 per
cent of his cases, Montgomery (1961) in 74 per cent, and Holleb and Farrow
(1962) in 72 per cent. Metastases in the corresponding axilla were established in
75 per cent of the present cases. Donegan (1967), among other authors, en-
countered axillary metastases in 56-7 per cent of a mammary carcinoma material
of non-pregnant women.
Considerable changes occur in the mammary gland even normally in the course
of pregnancy. This is probably why patients with breast carcinoma during
pregnancy often seek medical advice later than in normal circumstances. Several
authors, e.y. Westberg (1946) and Bunker and Peters (1963), have reported that
these patients come for treatment an average of 2 months later than normally.
This makes it understandable that the disease progresses readily. And it is the
degree of spread of the disease that is decisive for the prognosis. In cases in
which there were no metastases, Harrington (1937) obtained a 5-year survival
rate of 61-5 per cent and White (1955) 72t8 per cent. The corresponding survival
figures for the metastasising cases were only 5*7 and 6-3 per cent, respectively.
The 5-year survival rate for the total series in the present work was 43 per cent,
but 4 patients out of 5 (80 per cent) with carcinoma of Stage I and 8 out of 10
(80 per cent) in Stage II were alive after 5 years. Only 15 per cent of the patients
in Stage III and none of those in Stage IV survived. In considering the 5-year
survival rate it must be remembered that the majority of the cases (18/33) were
patients with far-advanced carcinoma of Stages III-IV. The material is relatively
small, of course, which precludes far-reaching conclusions, but everything suggests
that if patients with carcinoma of the breast that has begun during pregnancy are
treated while the disease is in the initial phases (Stages I-II) the prognosis is good
on the whole and hardly worse than the prognosis for mammary carcinoma in
young females. Brooks and Proffitt (1949) went as far as to suggest the possibility
of a better prognosis. On the other hand, the prognosis is poor in the more
advanced cases, Stages III-IV. Thus, it seems obvious that if mammary carci-
noma develops during pregnancy the earliest possible diagnosis is the crux of the
problem when seeking to improve the therapeutic results.
There is no point with such a small series in comparing the different therapeutic
methods. However, the same guide lines as are applicable in the treatment of
ordinary mammary carcinoma are valid here.
Interruption of pregnancy as a therapeutic measure for carcinoma of the
breast has been discussed widely. In a small nmixed group Adair (1953) obtained
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a higher survival rate when termination of pregnancy was included as part of the
therapy. A similar indication was reported by Holleb and Farrow (1962).
Montgomery (1962) recommended abortion in the early phase of pregnancy.
But many other authors, especially in recent times, have stated that there is not
sufficient statistical evidence of the clinical significance of termination of preg-
nancy (e.g. White, 1954; Miller, 1962; Schumacher, 1964) for the course of the
disease, andthatforthisreasonabortion cannot beregarded as being ofindisputable
significance in the treatment of the disease. Peters and Meakin (1965) stated
that there is to date no medical indication for interrupting a pregnancy during any
phase. Eight ofthe present cases underwent interruption ofpregnancy. Ofthese
patients, one with Stage I and 2 with Stage II of the disease were alive after 5
years; one patient with Stage II, 3 with Stage III and one with Stage IV died
during this time. The material was too small to evaluate the significance of
abortion (Table V), butit seemsthat it has not been possible to prove that abortion
TABLE V.-Correlation of Mammary Carcinomas Diagnosed During Pregnancy
uwith Pregnancy and 5-Year Survival
5-year survival
Pregnancy Pregnancy not
Clinica ]stage interrupted interrupted
St I . . 1/1 3/4
StII . . . 2/3 5/6
St III . . . 0/3 2/10
StIn . . . 0/1 0/3
Total . 3/8 10/23
has a beneficial effect on the end result. Thus, the decision to intervene must be
weighed in each individual case with reference to many other standpoints. How-
ever, the most important factor is early diagnosis and the most urgent surgical
measure possible for the removal of the tumour primarily, always regardless of
the stage of the pregnancy, and possibly combined with radiotherapy.
Surgical or roentgenologic castration was performed as a primary measure on
6 patients; 2 patients with Stage I ofthe disease were alive after5 years, the others
died during this period. Because of the small number of cases, no conclusions
can be drawn regarding the therapeutic value of this intervention in the more
advanced cases. Many authors (e.g. Rosemond 1954) oppose prophylactic
castration because its benefit has not yet been proved in larger series.
SUMMARY
The series comprised 33 patients with histologically verified mammary carci-
noma during pregnancy or lactation who were treated in 1940-61. This total was
0 9 per cent of all carcinomas of the breast treated at the same clinic during the
period. The mean age of the patients was 34-6 years. The clinical classification
by stage (TNM system) was: Stage I-6 cases, Stage II-10 cases, Stage III-13
cases, Stage IV-5 cases. Seventy-five per cent of the patients had metastases
in the homolateral axillary glands. The commonest therapeutic measure was
radical operation combined with postoperative radiotherapy. In addition,
termination of pregnancy was performed in 8 cases and primary castration in 6.
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The 5-year survival rate for the total series was 43 per cent, but it was 80 per cent
for patients in Stages I and II of the disease.
This investigation was supported by a grant from the Sigrid Juselius Founda-
tion and the President J. K. Paasikivi's Foundation for Cancer Research, Helsinki,
Finland.
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